
Can Scans and Tests Find Endometriosis? Know the Limits
What ultrasound, MRI, and newer “tests” can (and can’t) tell you

If you’ve been told your ultrasound was “normal,” but your pain, bowel symptoms, bleeding, or infertility keep going, it can feel like the system is asking you to doubt your own body. This is one of the most common—and most frustrating—parts of the endometriosis diagnostic journey.
The hard truth is that endometriosis can be real even when scans look fine. Imaging can be extremely helpful, but it’s not a simple yes/no detector. And while research is moving toward less invasive testing (blood, menstrual fluid, advanced imaging), most of those options are still not ready for routine care.
This article pulls together findings from multiple recent studies and expert guidance to answer the patient question underneath so many appointments: “If I have endometriosis, why can’t you see it on a scan?”
First, a key distinction: “Diagnosing endometriosis” vs “mapping endometriosis”
When clinicians order a scan, they’re often trying to do one (or both) of these things:
- Estimate whether endometriosis (or adenomyosis) is likely based on patterns that imaging can detect
- Map where disease might be—especially deep disease involving bowel, bladder, ligaments, or the rectovaginal area—so surgery can be planned more safely
That difference matters because a scan can be “negative” for what it’s good at detecting, while still missing other lesion types or locations. Recent research comparing ultrasound and MRI in deep pelvic endometriosis shows agreement between the two tests is not uniformly “good” or “bad”—it changes by anatomic site, which helps explain why two scans (or two radiology reports) can disagree.
What ultrasound can do well (and where it can fall short)
Ultrasound is often the first-line test—and it can be genuinely useful
Transvaginal ultrasound (TVUS) is widely used because it’s accessible, relatively low cost, and can identify certain common endometriosis-related findings, especially ovarian endometriomas (“chocolate cysts”). In one recent cohort looking at deep pelvic endometriosis, ultrasound and MRI had near-perfect agreement for endometriomas/hemorrhagic cysts—meaning when those cysts were present, both tests typically saw them.
Ultrasound can also be strong for some bowel-related questions when performed by an experienced operator. In that same comparison study, ultrasound reported more rectosigmoid involvement than MRI, and the authors suggested MRI can be limited by bowel gas, which can interfere with how lesions appear.
But ultrasound has blind spots—especially for certain deep locations or uterine features
Even with good technique, ultrasound may miss disease in certain areas. For example, that same head-to-head research found MRI identified involvement in places ultrasound did not detect, including the rectovaginal septum and round ligaments.
And if adenomyosis is part of the picture, the limitations can become even more relevant. Another study comparing transvaginal ultrasound and pelvic MRI (using surgery/pathology as the benchmark in a surgical population) reported MRI performed better for uterine size/shape–related markers (features they linked to adenomyosis, such as uterine enlargement/asymmetry or abnormal junctional zone shape). The practical takeaway isn’t “ultrasound is bad”—it’s that some questions are simply harder for ultrasound to answer reliably, and that may be why an MRI is recommended after a “normal” scan.
What MRI adds—and why it’s often the next step
When is MRI recommended?
A 2025 European expert consensus on MRI for endometriosis offers a straightforward, patient-relevant pathway: MRI is recommended when TVUS is inconclusive, or when TVUS is negative but symptoms persist. The same consensus also supports MRI before surgery or procedures to improve disease mapping, and after surgery if symptoms continue.
So if you’re thinking, “Why are we doing an MRI if the ultrasound was normal?”—you’re not overreacting. There is expert agreement that MRI can be the right next step in exactly that situation.
MRI isn’t “perfect,” but it can see different things than ultrasound
MRI can be particularly helpful for areas that are difficult to evaluate on ultrasound and for clarifying uterine findings relevant to adenomyosis. But importantly, MRI and ultrasound can be complementary rather than interchangeable. In recent site-by-site comparisons, some locations had only moderate agreement between the two methods—meaning it’s completely possible for one test to flag something the other does not.
That’s also why technique details matter more than most patients are told. For example, the way MRI is performed (use of contrast or not, medications to reduce bowel motion, bladder filling, whether vaginal/rectal gel is used) can affect what’s visible—especially around the rectovaginal region or vagina. If you’ve had an MRI and felt like the report didn’t match your symptoms, it may not mean “nothing is wrong”; it may mean the study wasn’t optimized for the specific question, or that the disease type/location is simply hard to detect.
Structured reporting can improve care—even if patients don’t always see it
The same MRI consensus emphasized using standardized reporting and classifications to help surgeons and radiologists communicate clearly. In real life, not every center uses structured reports consistently, but the direction of the field is clear: better mapping and clearer language lead to better planning.
If you’re heading toward surgery, it’s reasonable to ask if your imaging report is designed to support surgical decision-making (not just “no mass seen”).
Why imaging can still miss endometriosis (even when it’s severe)
Patients often assume a “good test” should reliably rule out disease. Endometriosis breaks that rule for several reasons:
- Not all endometriosis looks the same. Some lesions are superficial and small; others are deep and fibrotic; some form endometriomas. These behave differently on imaging.
- Location changes visibility. Studies comparing MRI and ultrasound show detection depends heavily on where disease is (bowel, bladder, ligaments, rectovaginal space), with some sites consistently trickier than others.
- Imaging shows patterns, not certainty. Even the more favorable studies acknowledge false positives and false negatives. Some imaging signs can overlap with other conditions (like fibroids or even normal uterine contractions affecting the junctional zone).
- Operator skill and protocol matter. Especially for ultrasound, experience is a major variable; for MRI, preparation and protocol can change what is seen.
This is a big reason many people cycle through “normal test” → “maybe IBS/anxiety” → “keep trying birth control” before they ever get a comprehensive evaluation.
What about PET scans or advanced “molecular imaging”?
It’s understandable to wonder: “If PET scans find cancer, why can’t they find endometriosis?”
A recent review of radiopharmaceutical (“molecular”) imaging explains why common PET imaging (like FDG PET/CT) is not reliable for endometriosis. Pelvic organs normally take up FDG, and endometriosis uptake is inconsistent—published results range widely, from very low lesion correlation to variable patient-level detection. Translation: FDG PET is not a dependable endometriosis test, and incidental uptake shouldn’t be treated as proof.
The more exciting future direction is targeted imaging—especially approaches aimed at fibrosis and inflammation, such as Fibroblast Activation Protein (FAP)–targeted tracers (FAPI). Tissue research suggests FAP is often expressed in endometriosis lesions and correlates with fibrosis-related features; animal studies show promising lesion-to-background uptake. But human evidence is still early (including case-level reports), and the review highlights a major practical challenge: normal uterine/ovarian uptake can obscure disease in premenopausal patients. For now, this is best viewed as promising but investigational.
Still in pain? Get expert help now
Our specialists are here to help you understand your condition and explore your treatment options.
Schedule Your Visit“Is there a blood test yet?” What current research really means
You may have seen headlines about a “new blood test for endometriosis.” The honest answer: not a clinically established one—but several lines of research are getting closer.
Blood-based miRNA panels: helpful for risk, not a standalone diagnosis (yet)
A 2026 study developing serum microRNA (miRNA) diagnostic models found moderate accuracy overall and better performance for deep infiltrating endometriosis (DIE) than for ovarian endometrioma. Notably, the DIE-focused model had high specificity (around 90%) but low sensitivity (about 51%)—meaning if it says “positive,” it may be meaningful, but a negative result would still miss many cases.
That pattern is common in early biomarker work: tests may eventually help triage (who should get expert imaging or referral sooner), rather than “replace laparoscopy.”
Immune-marker “liquid biopsy” panels: promising sensitivity, but false positives are a concern
Another 2026 study reported a circulating immune signature (a panel including inflammatory markers and soluble immune checkpoints) that distinguished surgical endometriosis cases from controls with high sensitivity (over 90%) and moderate specificity. That’s encouraging as a screening-style approach, but moderate specificity means a meaningful number of people without endometriosis could test positive.
Also important: participants were already going to surgery, and the sample didn’t include peritoneal-only disease—so we still don’t know how well it performs in the broader real-world population of people with pelvic pain.
Menstrual effluent testing: why it’s exciting, and why it’s not ready
One of the most patient-friendly research directions is testing menstrual effluent—fluid collected during a period (often with a menstrual cup). A 2026 systematic review found menstrual effluent reflects many biological features tied to endometriosis (progesterone resistance/decidualization problems, immune changes, pro-invasive signals, extracellular vesicle differences).
Some studies in that review reported remarkably high diagnostic accuracy for certain markers (for example, aromatase mRNA, TGF‑β1 protein, and functional decidualization assays). But there’s a catch that matters for patients: these were case–control studies with high risk of selection bias, and the review found no prospective validation cohorts. In plain language: Findings that seem strong in selected research populations often prove less effective in real-world clinics.
Still, this direction is worth watching because it could eventually mean home-based collection and a more direct window into uterine/endometrial biology than blood alone.
So why is laparoscopy still called the “gold standard”?
Because even the best available noninvasive methods can miss disease—and because laparoscopy can directly visualize lesions and allow biopsy for histology (tissue confirmation). Imaging can strongly suggest endometriosis, and it can help plan surgery, but it often can’t provide definitive proof for every lesion type or location.
That said, “gold standard” doesn’t mean “required for everyone right away.” It means that when the clinical stakes are high (severe symptoms, organ involvement, infertility decisions, treatment-resistant pain), and when imaging/clinical evaluation still leaves uncertainty, laparoscopy remains the most definitive tool we currently have.
Practical takeaways (how to use scans and tests without being gaslit)
- A normal scan does not equal “no endometriosis.” It may mean “no endometrioma” or “no clearly visible deep lesions on this protocol, in this set of locations.”
- Ask what the scan was meant to answer. Was it looking for endometriomas? Deep bowel disease? Adenomyosis? Surgical mapping?
- If symptoms persist after a negative or unclear ultrasound, MRI is a guideline-supported next step. Especially when deep disease or adenomyosis is suspected, or when planning surgery.
- Be cautious with headlines about new tests. Blood and menstrual-fluid tests are promising, but most are not yet validated for real-world diagnosis.
Questions to ask your doctor or radiology team
If you only ask a few things, make them these:
- “Based on my symptoms, what locations are you most concerned about (bowel, bladder, uterosacral ligaments, rectovaginal area, ovaries, uterus)?”
- “Was my ultrasound/MRI done in a way that’s optimized for deep endometriosis mapping?”
- “If imaging is negative, what’s our plan for next steps—MRI, referral to an endometriosis specialist, medical therapy trial, or discussing laparoscopy?”
- “Do you think adenomyosis could be contributing, and is MRI needed to clarify uterine findings?”
- “Can you walk me through the report in plain language—what was checked, what was seen, and what could still be missed?”
What we still don’t know (and why your results may differ from someone else’s)
Even with better imaging standards and promising biomarker research, major gaps remain:
Imaging studies show performance varies by site, protocol, and experience, and even head-to-head comparisons find only moderate agreement in several pelvic locations. Biomarker studies (blood miRNA panels, immune signatures, menstrual effluent markers) often look strongest in selected surgical cohorts, and many lack the prospective, real-world validation needed before they can guide care reliably.
Most importantly: endometriosis is not one uniform disease, and different subtypes (deep infiltrating vs ovarian endometrioma vs superficial peritoneal disease) may require different diagnostic tools. That’s why your journey can be long—and why “normal tests” should never be used to dismiss persistent symptoms.
In the next post in this series, we’ll talk about what happens when tests don’t give clear answers: how doctors think through other possible causes, and how you can advocate for yourself without getting stuck in an endless loop of “wait and see.”
References
Alkan, Kılıçkap. Agreement between magnetic resonance imaging and ultrasonography in deep pelvic endometriosis. Revista da Associação Médica Brasileira. 2025. PMID: 40172392 PMCID: PMC11964306
Dong, Li, Li. Efficacy of Transvaginal Ultrasound vs Pelvic MRI in Preoperative Diagnosis of Pelvic Endometriosis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2025. PMID: 40205719 PMCID: PMC11998614
Thomassin-Naggara, Dolciami, Chamie et al.. ESUR consensus MRI for endometriosis: indications, reporting, and classifications. European Radiology. 2025. PMID: 40425757 PMCID: PMC12559033
Napolitano, Speltri, Martini et al.. Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals. Molecules. 2025. PMID: 41515390 PMCID: PMC12786799
Ravaggi, Bergamaschi, Conforti et al.. Serum miRNA-based diagnostic models for endometriosis: from discovery to validation. Human Reproduction (Oxford, England). 2026. PMID: 41270284 PMCID: PMC12864148
. Endoscopic management of ureteral injuries arising from gynecologic procedures. BJUI Compass. 2026. PMID: 41696655 PMCID: PMC12894419
Hernández, Fernández-Medina, Araiz et al.. Identification of a circulating immunological signature as a liquid biopsy approach for the diagnosis of endometriosis. Scientific Reports. 2026. PMID: 41577934 PMCID: PMC12902033
Wei, Zhang, Weng et al.. Functional restoration of uterine architecture and fertility via a 3D-printed biomimetic scaffold: The role of macrophage-driven immunomodulation. Materials Today Bio. 2026. PMID: 41809374 PMCID: PMC12969655
Watrowski, Kostov, Tsoneva et al.. Menstrual Effluent in the Pathogenesis and Diagnosis of Endometriosis—A Systematic Review. Diagnostics. 2026. PMCID: PMC12984173
Quick Answers
Why do I have painful urination and pelvic cramping between periods?
Painful urination with pelvic cramping between periods can happen when the bladder, ureters, uterus, pelvic floor, or nerves are being irritated—sometimes in a way that still follows a subtle cycle pattern even if you’re not actively bleeding. Endometriosis can contribute by affecting the bladder wall or tissues around the bladder and ureters, and symptoms don’t have to include visible blood in the urine. Importantly, urinary tract endometriosis isn’t always “obviously urinary,” and ureter involvement can be quiet while still significant, which is why we take these symptoms seriously.
These symptoms can also come from conditions that overlap with (or mimic) endometriosis, such as bladder pain syndrome/interstitial cystitis, pelvic floor overactivity, adenomyosis-related uterine cramping, or other pelvic pain drivers. In our evaluation process, we focus on your full flare pattern—what triggers it, how it relates to your cycle, and whether urine tests have been repeatedly negative—then use targeted exam and the right imaging (often expertly interpreted ultrasound and/or MRI) to map what’s actually going on.
If you’re noticing recurring burning with urination, pressure, cramping, or symptoms that predictably flare mid-cycle or before your period, that pattern is useful diagnostic information—not something to dismiss. You can explore our urinary symptom and diagnostic evaluation resources to see how we approach “UTI-like” symptoms with negative cultures, and you’re welcome to reach out to schedule a consultation so our team can help you sort out whether this is bladder/ureter endometriosis, a look-alike condition, or a combination.
Why does ovarian cyst pain keep coming back?
Ovarian cyst pain can feel “recurrent” for a few different reasons. Some cysts are functional (they form with ovulation and then resolve), so the pain returns in a similar spot month after month even though it’s not the exact same cyst. In other cases, the cyst itself can come back or persist—especially if it’s an endometrioma (an ovarian cyst caused by endometriosis), which can behave differently than a simple cyst and may be associated with deeper pelvic disease.
Another common reason is that the cyst isn’t the whole story: endometriosis on the pelvic sidewall, uterosacral ligaments, bowel, bladder, or around the ovary can irritate the same nerves and tissues and make it feel like “my cyst is back” when the driver is actually inflammatory disease nearby. Adhesions (scar-like bands) can also tether the ovary and cause recurring pulling or sharp pain, even when imaging doesn’t show a large cyst. If your pain cycles, escalates, returns quickly after a “normal” ultrasound, or keeps recurring despite prior treatment, our team can help you map the pattern, interpret imaging with an endometriosis lens, and decide whether targeted evaluation and—when appropriate—excision surgery is the next best step.
Why do I get low back and leg pain during my period?
Low back and leg pain that predictably flares with your period can happen when pelvic inflammation irritates pain pathways that “refer” into the back, hips, buttocks, and down the leg. In some patients, endometriosis can be part of that story—either indirectly (pelvic inflammation and scarring increasing pressure and sensitivity around nearby nerves) or more directly if disease is affecting areas close to major nerves.
When period-related leg pain resembles sciatica—deep buttock pain, tingling, burning, or pain radiating down the back of the thigh—it raises the possibility of endometriosis-related sciatic irritation or pelvic floor involvement (often described as piriformis-type pressure on the nerve). These symptoms may start before bleeding, peak during the period, and linger afterward, and in more significant cases can be associated with weakness or changes in walking.
Because back and leg pain can also come from the spine, hips, or muscles, the key is the pattern and the full symptom “constellation,” including pelvic pain, bowel/bladder symptoms, or pain with sex. Our team can help you sort out whether your pain fits an endometriosis/adenomyosis pattern and, if needed, plan next-step evaluation such as targeted imaging and a strategy focused on lasting relief rather than temporary suppression.
Can endometriosis cause infertility and pelvic pain in your 20s?
Yes. Endometriosis can absolutely show up in your late 20s and it can be a driver of both chronic pelvic pain and fertility challenges. Pain can include severe or worsening period cramps, pain with sex, bowel or bladder pain, and “flare” patterns that track with your cycle—although symptom severity doesn’t always match how much disease is present.
Endometriosis can affect fertility in several ways, including adhesions that distort tubo‑ovarian anatomy, inflammation and immune signaling that interferes with fertilization or embryo development, and ovarian factors—especially when endometriomas are involved. For some patients, the uterine environment also matters, particularly when adenomyosis is present alongside endometriosis. In our practice, we focus on listening to your full symptom and fertility story and then building an evaluation that looks for endometriosis while also checking for common look‑alikes or coexisting issues, so we can tailor a plan to your goals—whether that’s pain relief, preserving fertility, or both.
Why do I have chronic fatigue and pelvic pain?
Chronic fatigue plus pelvic pain often feels “unexplainable” because it’s rarely caused by just one issue—and many of the most common drivers don’t show up on routine labs or a quick ultrasound. Endometriosis and adenomyosis can cause persistent pelvic pain, painful periods, bowel/bladder symptoms, and deep fatigue through inflammation, disrupted sleep, heavy bleeding (and possible iron deficiency), and the sheer energy cost of living with ongoing pain. It’s also common for more than one gynecologic condition to coexist—like fibroids, polyps, or benign cysts—so a single label may not fully match what you’re experiencing.
Another reason symptoms can persist is that the nervous system can become more pain-sensitive over time (often called central sensitization), meaning pain can spread, linger outside your cycle, or feel disproportionate to what imaging shows. In those cases, symptom relief alone can miss the bigger picture: we think in terms of both treating disease (for example, addressing endometriosis lesions or uterine drivers like adenomyosis/fibroids) and building a personalized pain-management plan so your body can “turn down the volume” on pain signals.
If your fatigue and pelvic pain have been brushed off or left without a clear plan, our team can help you sort through the likely contributors, including endometriosis/adenomyosis and common coexisting conditions, and map next steps that fit your goals. You can explore our educational resources on fatigue, chronic pelvic pain, and comprehensive treatment approaches, and reach out to schedule a consultation when you’re ready.


